Navigation Links
Figuring out methane's role in the climate puzzle
Date:7/9/2014

The U.S. may be on the verge of an economy driven by methane, the primary component of natural gas, which burns cleaner than coal and is undergoing a production boom. It has poised the country as a top fuel producer globally, but recent research is casting serious doubts over just how climate-friendly it is, according to an article in Chemical & Engineering News (C&EN), the weekly news magazine of the American Chemical Society.

In the article, Jeff Johnson, a senior correspondent at C&EN, explains that when burned as a fuel to produce electricity, methane emits about half as much carbon dioxide (CO2), a major greenhouse gas, as coal. But not all methane gets burned as fuel. Some of the gas is released, either through leaks or intentional venting from oil and gas wells, into the atmosphere. Although it is present in much smaller amounts in the atmosphere compared to CO2 the primary target for climate change regulations methane has 86 times more global warming potential. And estimates vary significantly over just how much is escaping into the air.

To get a better handle on the methane picture, researchers are planning more detailed studies to estimate the gas's emissions from oil and gas operations. In parallel, the Environmental Protection Agency, which has so far been reluctant to directly regulate methane emissions, plans to review the situation. If deemed necessary, the agency would propose new regulations by 2016.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. For corals adapting to climate change, its survival of the fattest -- and most flexible
2. Study reveals strong links between Antarctic climate, food web
3. Fine-scale climate model projections predict malaria at local levels
4. Putting a price tag on the 2° climate target
5. Study: To address climate change, nothing substitutes for reducing CO2 emissions
6. Climate change and the ecology of fear
7. Capturing CO2 emissions needed to meet climate targets
8. A win-win-win solution for biofuel, climate, and biodiversity
9. New study quantifies the effects of climate change in Europe
10. Restricting competitors could help threatened species cope with climate change
11. Botany: Leafing out and climate change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: